Stem Point Capital LP Krystal Biotech, Inc. Transaction History
Stem Point Capital LP
- $378 Billion
- Q1 2024
A detailed history of Stem Point Capital LP transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 20,000 shares of KRYS stock, worth $4.14 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$4.14 Million% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding KRYS
# of Institutions
264Shares Held
21.5MCall Options Held
462KPut Options Held
723K-
Avoro Capital Advisors LLC New York, NY2.56MShares$529 Million5.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$504 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$374 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.51MShares$312 Million10.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$205 Million9.23% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $5.32B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...